A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety of MEDI-559 in Healthy 1 to <24 Month-Old Children
NCT00767416
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
116
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
BIOLOGICAL:
MEDI-559
OTHER:
Placebo
Sponsor
MedImmune LLC